Posted on November 29, 2012 by Sitemaster
New data from the ARTS study, reported in European Urology, suggests that dutateride may have a role in the treatment of men with biochemical failure after radical first-line therapy for prostate cancer. … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: ARTS, biochemical progression, dutasteride, outcome, second-line | 2 Comments »
Posted on June 7, 2009 by Sitemaster
Today’s news reports deal with:
- Diabetes, PSA, and prostate cancer risk
- Magnetic resonance spectroscopic imaging
- Ongoing trials of dutasteride as early stage treatment for prostate cancer … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment, Uncategorized | Tagged: ARTS, diabetes, dutasteride, magmentic resonance spectroscopic imaging, MSRI, REDEEM, risk | Leave a comment »
Posted on March 18, 2009 by Sitemaster
Today we cover reports on:
- The incidence of prostate cancer among older HIV-positive men
- ARTS and the potential of dutasteride in treatment of patients with biochemical recurrence
- PET scans and their use in detection of biochemical recurrence
- Chemotherapy in treatment of prostate cancer … READ MORE …
Filed under: Diagnosis, Drugs in development, Management, Risk, Treatment, Uncategorized | Tagged: ARTS, chemotherapy, dutasteride, HIV, incidence, PET scan | Leave a comment »